Dissolved and financials
CVR: 39950421
DKK 0
Gross profit
Net result: DKK 0
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 29 September 2022
CVR · view overview
No headcount reported
Director role ended: Pernille Bigaard
CVR · 17/05/2022
View the full event history
Oncostress Therapeutics IVS was a Danish company of the type Iværksætterselskab based in København S, founded in 2018. The company has been dissolved on 29 September 2022. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2020 report amounted to DKK 0.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202001/01/2020 – 31/12/2020 | 0 | 0 | 0 | 0 | - |
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringNo. Oncostress Therapeutics IVS is registered in the Danish CVR register with the status Dissolved and ceased on 29 September 2022.
The CVR number of Oncostress Therapeutics IVS is 39950421.
In 2020, Oncostress Therapeutics IVS reported a gross profit of DKK 0.
Oncostress Therapeutics IVS was founded on 17 October 2018.
Oncostress Therapeutics IVS was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi (industry code 721100).
Oncostress Therapeutics IVS was located at c/o Claus Storgaard Sørensen, Messinavej 11 1., 2300 København S.
Oncostress Therapeutics IVS was dissolved on September 29, 2022.
As of May 17, 2022, Pernille Bigaard has stepped down as liquidator of Oncostress Therapeutics IVS.
On May 17, 2022, Oncostress Therapeutics IVS exited liquidation.
As of February 21, 2022, Pernille Bigaard is registered as liquidator of Oncostress Therapeutics IVS.
On February 21, 2022, Oncostress Therapeutics IVS entered liquidation.
As of January 25, 2022, Claus Storgaard Sørensen has stepped down as adm. dir. of Oncostress Therapeutics IVS.
Oncostress Therapeutics IVS has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK 0.
Oncostress Therapeutics IVS has published its interim report for the period October 17, 2018 – December 31, 2019.
As of October 17, 2018, Claus Storgaard Sørensen is registered as adm. dir. of Oncostress Therapeutics IVS.
Oncostress Therapeutics IVS was founded on October 17, 2018.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at drive forretning med digital markedsføring og strategi samt enhver i forbindelse hermed stående virksomhed.
